Previous 10 | Next 10 |
Inogen, Inc. (NASDAQ: INGN ), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Stanislav Glezer, MD has been appointed to the role of Chief Technol...
Expands Prescriber-Facing Sales Force and Enhances Critical Capabilities with the Goal of Driving Top-Line Growth Inogen, Inc. (NASDAQ: INGN ), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory produ...
Gainers: Gevo (NASDAQ:GEVO) +35%. American Virtual Cloud Technologies (NASDAQ:AVCT) +33%. Rocket Lab (NASDAQ:RKLB) +32%. Torrid (NYSE:CURV) +30%. Montauk (NASDAQ:MNTK) +25%. Impel (NASDAQ:IMPL) +22%. Gold Royalty (NYSE:GROY) +22%. ProQR (NASDAQ:PRQR) +21%. Hyzon (NASDAQ:HYZN) +21%. Rockley (N...
Gainers: ProQR Therapeutics (NASDAQ:PRQR) +22%, Centessa Pharmaceuticals CNTA +22%, Kiromic BioPharma (NASDAQ:KRBP) +19%, Trinity Biotech TRIB +16%, Enveric Biosciences (NASDAQ:ENVB) +14%. Losers: Humanigen HGEN -54%, Invacare IVC -34%,...
Inogen was hit hard on management's guidance for weaker second half revenue, as semiconductor supply shortages will limit sales volumes and drive weaker gross margins. Underlying sales trends have been better than expected, with growth not only in the B2B and rental channels, but the ...
The following slide deck was published by Inogen, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Inogen, Inc. 2021 Q2 - Results - Earnings Call Presentation
Gainers: Profound Medical (NASDAQ:PROF) +28%, STAAR Surgical (NASDAQ:STAA) +19%, AdaptHealth (NASDAQ:AHCO) +17%, Flora Growth (NASDAQ:FLGC) +16%, Invacare (NYSE:IVC) +15%. Losers: Inogen (NASDAQ:INGN) -32%, Karyopharm Therapeutics (NASDAQ:KPTI) ...
Inogen, Inc. (INGN) Q2 2021 Earnings Conference Call May 04, 2021 4:30 PM ET Company Participants Jason Somer - Executive Vice President & General Counsel Nabil Shabshab - President & Chief Executive Officer Alison Bauerlein - Founder, Chief Financial Officer & Executive Vice Pres...
Image source: The Motley Fool. Inogen, inc (NASDAQ: INGN) Q2 2021 Earnings Call Aug 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Inogen, inc (INGN) Q2 2021 Earnings Call Transcript
Inogen (NASDAQ:INGN): Q2 GAAP EPS of $0.22 beats by $0.33. Revenue of $101.56M (+41.7% Y/Y) beats by $12.81M. Press Release For further details see: Inogen EPS beats by $0.33, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...